Antecip Bioventures II LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Antecip Bioventures II LLC
Quantité totale PI 341
Rang # Quantité totale PI 3 837
Note d'activité PI 3,2/5.0    222
Rang # Activité PI 3 080

Brevets

Marques

300 0
15 0
26 0
0
 
Dernier brevet 2025 - Bupropion as a modulator of drug...
Premier brevet 2012 - Implantable polymeric device for...

Derniers inventions, produits et services

2025 Invention Bupropion as a modulator of drug activity. Dosage forms, drug delivery systems, and methods rela...
Invention Compounds and combinations thereof for treating neurological and psychiatric conditions. This di...
Invention Bupropion as a modulator of drug activity. This disclosure relates to administration of a combin...
Invention Bupropion dosage forms with reduced food and alcohol dosing effects. This disclosure relates to ...
Invention Compounds and combinations thereof for treating neurological and psychiatric conditions. Dosage ...
Invention Compounds and combinations thereof for treating neurological and psychiatric conditions. Dosage f...
Invention Compounds and combinations thereof for treating neurological and psychiatric conditions. This dis...
2024 Invention Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextrometh...
Invention Treatment of depression. This disclosure relates to administration of a combination of: 1) about...
Invention Combination of dextromethorphan and bupropion for treating depression. This disclosure relates t...
Invention Combination of dextromethorphan and bupropion for treating depression. Disclosed herein are meth...
Invention Bupropion dosage forms with reduced food and alcohol dosing effects. This disclosure relates to d...
Invention Bupropion and dextromethorphan for treating nicotine addiction. Disclosed herein are methods of ...
Invention Method of maintaining remission of depressive symptoms. Disclosed herein are methods of treating...
2023 Invention Bupropion and dextromethorphan for reduction of suicide risk in depression patients. This disclos...
Invention Bupropion as a modulator of drug activity. Disclosed herein are methods of treating neurological...
Invention Bupropion as a modulator of drug activity. This disclosure relates to administration of a combina...
Invention Combination of dextromethorphan and bupropion for treating depression. This disclosure relates to...
Invention Compositions for oral administration of zoledronic acid or related compounds for treating disease...
Invention Pharmaceutical compositions comprising bupropion and cysteine. This disclosure relates to pharmac...